Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Building data quality into clinical trials.

William J Crerand1, Jana Lamb, Vera Rulon

  • 1Pfizer, Inc., USA.

Journal of AHIMA
|November 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival and Economic Impact of Rapid Prostate-Specific Antigen Doubling Time in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.

Clinical genitourinary cancer·2023
Same author

Correction: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate.

Prostate cancer and prostatic diseases·2022
Same author

Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate.

Prostate cancer and prostatic diseases·2022
Same author

Using Artificial Intelligence With Natural Language Processing to Combine Electronic Health Record's Structured and Free Text Data to Identify Nonvalvular Atrial Fibrillation to Decrease Strokes and Death: Evaluation and Case-Control Study.

Journal of medical Internet research·2021
Same author

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer.

Prostate cancer and prostatic diseases·2021
Same author

Real-World Data of Palbociclib in Combination With Endocrine Therapy for the Treatment of Metastatic Breast Cancer in Men.

Clinical pharmacology and therapeutics·2021

High-quality clinical trial data are crucial. Pharmaceutical companies employ various strategies, from case report form design to database release, to ensure data integrity and reliability.

Area of Science:

  • Clinical Research
  • Data Management
  • Pharmaceutical Science

Background:

  • Data quality is paramount in pharmaceutical clinical trials.
  • Ensuring data integrity from collection to release is a key challenge.
  • Current strategies focus on robust data management practices.

Purpose of the Study:

  • To examine pharmaceutical companies' strategies for ensuring high-quality clinical trial data.
  • To highlight approaches from initial data collection to final database release.
  • To provide insights into best practices in clinical data management.

Main Methods:

  • Review of current data collection and management strategies in pharmaceutical trials.
  • Emphasis on case report form (CRF) development.

Related Experiment Videos

  • Examination of processes leading to database release.

    • Main Results:

    • Pharmaceutical companies utilize diverse strategies to optimize data quality.
    • Case report form development is a critical initial step.
    • Comprehensive processes are in place from data entry to database lock.

    Conclusions:

    • Effective data collection and management strategies are essential for reliable clinical trial outcomes.
    • A systematic approach from CRF design to database release ensures data integrity.
    • Continuous improvement in data management practices is vital for pharmaceutical research.